Your Article Summary
See Latest ArticlesPharmacological Management of Delirium in Hospitalized Adults - A Systematic Evidence Review
Journal of General Internal Medicine, 05/12/09
Campbell N et al. - The existing limited data indicates no superiority for second-generation antipsychotics over haloperidol in managing delirium. Although preliminary results suggest delirium prevention may be accomplished through various mechanisms, further studies are necessary to prove effectiveness.
Methods- Three reviewers independently extracted the data for participants, interventions and outcome measures, and critically appraised each study using the JADAD scale.
- Searched Medline, PubMed, the Cochrane Register of Controlled Trials, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) information systems from January 1966 to October 2008.
- We included randomized, controlled trials comparing pharmacologic compounds either to each other or placebo.
- This study excluded non-comparison trials, studies with patients aged < 18 years, a history of an Axis I psychiatric disorder, and patients with alcohol-related delirium.
- This study identified 13 studies that met our inclusion criteria and evaluated 15 compounds:
- second-generation antipsychotics,
- first-generation antipsychotics,
- cholinergic enhancers,
- an antiepileptic agent,
- an inhaled anesthetic,
- injectable sedatives,
- and a benzodiazepine.
- Four trials evaluated delirium treatment and suggested no differences in efficacy or safety among the evaluated treatment methods (first and second generation antipsychotics).
- Neither cholinesterase inhibitors nor procholinergic drugs were effective in preventing delirium.
- Multiple studies, however, suggest either shorter severity and duration, or prevention of delirium with the use of haloperidol, risperidone, gabapentin, or a mixture of sedatives in patients undergoing elective or emergent surgical procedures.
Today in Geriatric Psych...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of agitation and aggression associated with Alzheimers disease: controversies and possible solutions
Current Opinion in Psychiatry, 10/12/09
What is the association between depression and Alzheimer's disease?
Expert Review of Neurotherapeutics, 11/19/09
The Occurence of Mood and Anxiety Disorders in Heart Transplant Recipients
Transplantation Proceedings, 11/02/09
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Is Monotherapy as Good as Polypharmacy in Long-Term Treatment of Bipolar Disorder
Canadian Journal of Psychiatry, 11/16/09
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09
Today in Schizophrenia/Psychosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/28/09
Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder
Schizophrenia Research, 11/18/09
Changes in metabolic syndrome parameters in patients with schizoaffective disorder who participated in a randomized, placebo-controlled trial of topiramate
Asian Journal of Psychiatry, 11/09/09